(NASDAQ: IFRX) Inflarx Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.55%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.21%.
Inflarx Nv's earnings in 2026 is -$50,485,178.On average, 9 Wall Street analysts forecast IFRX's earnings for 2026 to be -$26,336,289, with the lowest IFRX earnings forecast at -$39,674,321, and the highest IFRX earnings forecast at -$13,663,350. On average, 9 Wall Street analysts forecast IFRX's earnings for 2027 to be -$31,179,910, with the lowest IFRX earnings forecast at -$55,260,661, and the highest IFRX earnings forecast at -$9,867,975.
In 2028, IFRX is forecast to generate -$31,411,247 in earnings, with the lowest earnings forecast at -$48,175,961 and the highest earnings forecast at -$8,349,825.